Skip to content

Dysembryoplastic Neuroepithelial Tumour (DNET)

Summary

fleuron

  • Benign, slow-growing glioneuronal tumour typically presenting with drug-resistant epilepsy in children and young adults
  • Characterised by cortical location, multinodular architecture, and specific glioneuronal element
  • Imaging shows a cortical-based, multicystic lesion with minimal or no enhancement

Pathophysiology

  • Arises from abnormal development of neuroepithelial cells during embryogenesis
  • Composed of oligodendrocyte-like cells, astrocytes, and floating neurons
  • Typically lacks mitotic activity and necrosis
  • Associated with cortical dysplasia in up to 80% of cases

Demographics

  • Most common in children and young adults
  • Mean age at diagnosis: 14-18 years
  • Slight male predominance (male:female ratio 1.2:1)
  • Accounts for 0.2-0.8% of all intracranial neoplasms

Diagnosis

  • Clinical presentation:
    • Drug-resistant focal epilepsy (>90% of cases)
    • Seizure onset typically in childhood or adolescence
    • Normal neurological examination in most patients
  • Histopathology:
    • WHO grade 1 tumour
    • Specific glioneuronal element: oligodendrocyte-like cells arranged in columns
    • Floating neurons in a mucoid matrix
    • Immunohistochemistry: CD34 positivity in oligodendrocyte-like cells

Imaging

  • CT:
    • Hypodense cortical-based lesion
    • Calcifications in 20-30% of cases
  • MRI:
    • T1: Hypointense to grey matter
    • T2/FLAIR: Hyperintense, multicystic appearance ("bubbly" or "soap bubble" appearance)
    • Minimal or no enhancement after gadolinium administration
    • No perilesional oedema
    • "Bright rim sign": T2 hyperintense rim at the tumour-cortex interface (specific for DNET)
  • Advanced imaging:
    • MR spectroscopy: Reduced N-acetylaspartate, elevated myoinositol
    • Perfusion imaging: Low relative cerebral blood volume

panels-1

  • Soap-bubble non-enhancing lesion in the left uncus has not changed in over 6 years giving a radiological diagnosis of DNET.

Treatment

  • Surgical resection is the treatment of choice
    • Complete resection achieves seizure freedom in 80-90% of cases
  • Adjuvant therapy rarely required due to benign nature
  • Anti-epileptic drugs for seizure control
  • Long-term follow-up recommended due to rare cases of malignant transformation
  • Prognosis is excellent with complete resection
    • 10-year overall survival rate >90%

Differential diagnosis

Differential Diagnosis Differentiating Feature
Low-grade glioma DNETs have a characteristic "bubbly" appearance on T2-weighted MRI, while low-grade gliomas typically appear more homogeneous
Ganglioglioma DNETs lack the calcifications often seen in gangliogliomas on CT scans
Focal cortical dysplasia DNETs have a well-defined border, while focal cortical dysplasia often has blurred gray-white matter junction
Oligodendroglioma DNETs are typically located in the temporal lobe, while oligodendrogliomas are more common in the frontal lobes
Pleomorphic xanthoastrocytoma DNETs do not enhance with contrast, unlike pleomorphic xanthoastrocytomas which often show strong enhancement
Pilocytic astrocytoma DNETs are typically cortical, while pilocytic astrocytomas are often found in the cerebellum or optic pathways
Cavernous malformation DNETs lack the characteristic "popcorn" appearance and haemosiderin rim seen in cavernous malformations on MRI
Glioneural tumours DNETs have a specific "floating neuron" histological pattern, which is absent in other glioneural tumours
Encephalocele DNETs do not show direct communication with the subarachnoid space, unlike encephaloceles
Cortical tuber (in tuberous sclerosis) DNETs are solitary lesions, while cortical tubers are typically multiple